Big Money Sentiment Indicator of Lemaitre Vascular Inc (NASDAQ:LMAT) Dropped in Q3 2018 to 1.37

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Corporate Logo

“Big money” Positions

“Big money sentiment for Lemaitre Vascular Inc (NASDAQ:LMAT) in 2018 Q3 decreased to 1.37, SEC filings reveal. That’s down -1.04, from 2018Q2’s 2.41. 71 active investment managers started new or increased holdings, while 52 decreased and sold positions in Lemaitre Vascular Inc so the sentiment dived. Funds own 15.38 million shares, up from 14.96 million shares in 2018Q2. Funds holding Lemaitre Vascular Inc in top 10 was flat from 1 to 1 for the same number . 13 Investors Sold All; 39 Reduced Holdings; 55 increased holdings while 16 active investment managers bought holdings.

Most Lemaitre Vascular Inc Investors

As of 2018 Q3 Awm Investment Company Inc. has 2.11% invested in Lemaitre Vascular Inc. As of 2018 Q3, 395,935 shares of Lemaitre Vascular Inc are owned by Thomson Horstmann & Bryant Inc. Furthermore, Ranger Investment Management L.P. reported 722,692 shares in Lemaitre Vascular Inc equivalent to 1.85% of its long stock exposure. The Minnesota-based fund Summit Creek Advisors Llc have invested about 1.82% of the investment professional’s stock portfolio in Lemaitre Vascular Inc. The Pennsylvania-based fund Conestoga Capital Advisors Llc looks positive on Lemaitre Vascular Inc, possessing 1.61 million shares.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.The company has $447.26 million market cap. The firm provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins.The P/E ratio is 21.75. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature.

The stock increased 0.71% or $0.16 during the last trading session, hitting $22.84.LeMaitre Vascular, Inc. has volume of 3,097 shares. Since January 14, 2018 LMAT has declined 19.31% and is downtrending. LMAT underperformed by 19.31% the S&P 500.

LeMaitre Vascular, Inc. (NASDAQ:LMAT)’s quarterly earnings will be revealed on February, 20., RTT reports. Analysts have anticipation on stock’s earnings per share of $0.18. That’s down 14.29 % from last year’s $0.21 earnings per share. LMAT’s profit could be $3.52M with 31.72 P/E in case $0.18 earnings per share is revealed. -14.29 % negative EPS growth is what Wall Street’s sees after $0.21 reported EPS previous quarter.

Sg Americas Securities Ltd Llc has 7,205 shs. Wasatch Advsrs accumulated 151,535 shs. Trexquant Investment L P owns 0.02% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT) for 5,589 shs. Quantitative Systematic Strategies Ltd Liability holds 0.05% or 6,245 shs. Globeflex Capital Lp has 0.12% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Menta Lc stated it has 0.11% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Colonial Tru has 14,407 shs for 0.1% of their capital. Invesco Ltd holds 0% or 290,506 shs. State Of Alaska Department Of Revenue holds 0% or 4,988 shs in its capital. The New York-based Morgan Stanley has invested 0% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Guggenheim Cap Ltd Company reported 0% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Panagora Asset Mngmt holds 0% or 3,555 shs. Teachers Retirement System Of The State Of Kentucky reported 0% stake. State Board Of Administration Of Florida Retirement Systems holds 0% or 8,244 shs. Alps Advsr reported 13,857 shs stake.

LeMaitre Vascular, Inc. had 4 selling transactions and 0 insider purchases since July 25, 2018. This’s net activity of $2.60 million. LeMaitre George W sold $1.49M worth of LeMaitre Vascular, Inc. (NASDAQ:LMAT) or 39,820 shs on Wednesday, July 25. 20,000 shs valued at $558,588 were sold by Thomas Michael H on Tuesday, October 30.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Ratings Coverage

Total analysts of 2 have positions in LeMaitre Vascular (NASDAQ:LMAT) as follows: 1 rated it a “Buy”, 0 with “Sell” and 1 with “Hold”. The positive are 50%. Since October 8, 2018 according to StockzIntelligence Inc LeMaitre Vascular has 2 analyst reports. On Monday, October 8 the rating was maintained by Canaccord Genuity with “Hold”. On Monday, October 8 Roth Capital upgraded LeMaitre Vascular, Inc. (NASDAQ:LMAT) rating. Roth Capital has “Buy” rating and $34 target.

For more LeMaitre Vascular, Inc. (NASDAQ:LMAT) news published recently go to: Investorplace.com, Globenewswire.com, Globenewswire.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “5 Healthcare Stocks That Are Down, But Not Out! – Investorplace.com” published on August 29, 2018, “LeMaitre Vascular to Present at Upcoming Investor Conferences – GlobeNewswire” on September 07, 2018, “LeMaitre Vascular Divests General Surgery Product Lines – GlobeNewswire” with a publish date: April 05, 2018, “LeMaitre Vascular Announces Preliminary Q3 2018 Results Nasdaq:LMAT – GlobeNewswire” and the last “LeMaitre Vascular, Inc. (LMAT) Management on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: July 27, 2018.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.